However, in a chronic disease such as MS, characterized by an unpredictable course with exacerbations and progression over time, more precise and more frequent assessments are needed to guide increasingly complex treatment decisions.Cleveland Clinic???s Mellen Center for Multiple Sclerosis Treatment and Research, under the leadership of Richard Rudick, MD, together with the team of Jay Alberts, Ph